Brian M. Strem - Oct 21, 2021 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Signature
/s/ Sarah Romano, Attorney-in-Fact*
Stock symbol
KPRX
Transactions as of
Oct 21, 2021
Transactions value $
$25,173
Form type
4
Date filed
11/22/2021, 03:35 PM
Previous filing
Aug 2, 2021
Next filing
Feb 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPRX Common Stock Award +9.52K 9.52K Oct 21, 2021 Direct F1
transaction KPRX Common Stock Purchase $25.2K +17.9K +187.59% $1.41 27.4K Nov 18, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.395 to $1.41, inclusive. The reporting person hereby undertakes to provide to Kiora Pharmaceuticals, Inc., any security holder of Kiora Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.